{"id":"W2887847211","doi":"10.1080/23723556.2018.1481814","title":"CDC25 as a common therapeutic target for triple-negative breast cancer - the challenges ahead","year":2018,"lang":"en","type":"article","venue":"Molecular & Cellular Oncology","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; University Health Network","funders":"Congressionally Directed Medical Research Programs; Canadian Cancer Society Research Institute; Terry Fox Research Institute; Government of Canada; Israel Cancer Research Fund","keywords":"Cdc25; PTEN; Triple-negative breast cancer; Breast cancer; Cancer research; Phosphatase; PIN1; Cancer; Medicine; Oncology; Internal medicine; PI3K/AKT/mTOR pathway; Biology; Enzyme; Phosphorylation; Signal transduction; Cell biology; Biochemistry; Cell cycle","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004034242,0.0006720175,0.001711835,0.0006530776,0.0009845579,0.003524574,0.001132281,0.003184003,0.003486408],"category_scores_gemma":[0.001318357,0.0003561121,0.0005420074,0.0005338417,0.001711746,0.004547696,0.001629681,0.005411182,0.001668009],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001330892,"about_ca_system_score_gemma":0.002109633,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005508639,"about_ca_topic_score_gemma":0.003932847,"domain_scores_codex":[0.9991919,0.0002050155,0.00008253074,0.00009555216,0.0002584528,0.0001665258],"domain_scores_gemma":[0.9991248,0.0002860189,0.0001165729,0.0000527684,0.0001884864,0.000231212],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001320196,0.0004471399,0.001900878,0.002743907,0.0001355894,0.002568236,0.0003697377,0.002102319,0.05464314,0.0575639,0.1141454,0.7620596],"study_design_scores_gemma":[0.0001828016,0.001175802,0.001236667,0.0007856354,0.0001768087,0.004968209,0.000800322,0.001796176,0.01557132,0.02615337,0.9470625,0.00009041672],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01685341,0.8075516,0.00790374,0.1522317,0.005050418,0.0000836525,0.0001680992,0.0002917227,0.009865589],"genre_scores_gemma":[0.1319712,0.7952614,0.01019922,0.0389626,0.009771,0.0002133983,0.0002797958,0.0001067237,0.01323463],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004034242,"threshold_uncertainty_score":0.02133536,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01939120539736509,"score_gpt":0.3099409578009168,"score_spread":0.2905497524035517,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}